Analogously, Vidal et al. revealed that lower concentrations of the plasma IGFBP-1 were associated with an increased risk of CRC, whereas higher levels of IGFBP-1 were related with a decreased risk of CRC in men only61. This evidence concerns the gene IGFBP1 and colorectal carcinoma.